Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Repligen Spinal Drug Gets US and EU Incentives

By Pharmaceutical Processing | June 23, 2011

 

WALTHAM, Mass.
(AP) — Repligen will be awarded incentives by both the U.S. and Europe
as it develops a drug to treat the neuromuscular disease spinal muscular
atrophy, the company said today.

The drug RG3039 has already received fast track status in
the U.S.
That means the Food and Drug Administration will make faster decisions about
Repligen’s marketing application. Regulators in the European Union gave the
drug orphan drug status, which comes with up to 10 years of marketing
exclusivity if approved. Orphan drug and fast track status are used to
encourage treatments for rare diseases, or conditions that have few treatment
options.

RG3039 received orphan drug status in the U.S., which
includes up to seven years of marketing exclusivity.

The company said it has received approval for an early stage
clinical trial of the drug. Repligen Corp. plans to test RG3039 on 40 healthy
people to evaluate its safety and its effects on the body.

The company said RG3039 is the first drug developed
specifically to treat spinal muscular atrophy.

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards